United States set
language
Menu Shopping cart $0 Search

epicGEN kits

epicGEN introduces a next-generation technology for precise examination of mutation status in target biomarkers. The technology is based on ultra-deep sequencing of selectively enriched genomic regions, utilizing an optimized hybrid capture system for maximum specificity and sensitivity.

The epicGEN technology is highly precise, ultra-sensitive, specific, and efficient – perfectly suited for clinical diagnostics and translational research, offering new advantages for analyzing complex genetic variations.

15550

New generation of NGS panels

Our epicGEN technology is designed to enable high-efficiency hybrid capture, allowing parallel processing of samples for all targeted genes with maximum specificity and uniform coverage.
epicGEN delivers user-friendly diagnostic NGS kits with exceptional analytical performance and optimized hybrid capture technology, ensuring high precision and efficiency for laboratories of any size.


See epicGEN portfolio 

 


Five reasons why epicGEN stands out

  • Specific

    Highly specific oligonucleotides precisely target desired sequences, minimizing non-specific enrichment and improving coverage.

  • Uniform

    Optimized design ensures consistent coverage across target regions, maximizing sequencing efficiency and reliability.

  • Accurate

    Minimizes off-target binding, reducing interference from non-coding and repetitive genomic regions for greater precision.

  • Sensitive

    Enables reliable enrichment from just less than 1ng of DNA, supporting analysis of challenging samples like cfDNA, FFPE tissues, and rare biological materials.

  • Powerful

    Detects somatic mutations at VAF >1% with sufficient sequencing depth (~500×), ensuring high sensitivity in mutation analysis.

Are you interested in more? Contact our product manager.

15784

 

Iveta Tóthová, PhD.

Product & Scientific Manager
+420 724 873 015
tothova@biovendor-mdx.com

 

 

Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
zavřít